Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia

Malaysian Journal of Medical Sciences

Volumn 20, Issue 2, 2013, Pages 42-47

  Abdullah, Saleh Mohammed ^a  

^a JAZAN UNIVERSITY   (Saudi Arabia)

Author keywords

Blood donors; Hepatitis B virus; Hepatitis C virus; Jazan; Prevalence; Saudi Arabia

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD SAFETY; BLOOD SAMPLING; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RATE; INFECTION RISK; RETROSPECTIVE STUDY; SAUDI ARABIA; SCREENING TEST; SEROPREVALENCE;

EID: 84874627359     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004;70(1):15-28.
2. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunology features of hepatic injury and viral persistence. Hepatology. 1999;30(3):595-601.
3. Mahoney FJ. Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection. Clin Microbiol Rev. 1999;12(2):351-366.
4. Blumberg BS. Australia antigen and the biology of hepatitis B. Sci. 1977;197(4298):17-25
5. Purcell RH. The discovery of the hepatitis viruses. Gastroenterology. 1993;104(4):955-563.
6. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S, et al. Serological pattern 'anti-HBc alone': report on a workshop. J Med Virol. 2000;62(4): 450-455.
7. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus. Indian J Med Res. 2006;123(1): 37-42.
8. Badur S, Akgun A. Diagnosis of hepatitis B infections and monitoring of treatment. J ClinVirol. 2001;21(3):229-237.
9. Vitale F, Tramuto F, Orlando A, VizziniG Melo V, Cerame G, Mazzucco W, et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol. 2008;80(4):577-582.
10. Jane P. At last a global response to viral hepatitis. Bull World Health Organ. 2010;88(11):801-802.
11. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(5):359-362.
12. Alfredo A, Patrizia P, Chamellon L, Benvegnu L, Belussi F, DeMitiri MS. The interaction between hepatitis B and C viruses in acute and chronic liver disease. J Hepatol. 1995;22(1):38-41.
13. Shobokshi OA, Serebour FE, Skakni L. HBV surface gene mutants and their emerging role in the efficacy of HBV vaccination program. Ann Saudi Med. 1999;19(2):87-92.
14. Fathalla SE, Namnyak SS, Al Jama A, Rabaria Bautista MM. The prevalence of HBV surface antigen in healthy subjects resident in the eastern Province of Saudi Arabia. Saudi Med J. 1985;6(6):236-239.
15. Bashawri LA, Fawaz NA, Ahmed MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in Eastern Saudi Arabia, 1998-2001. Clin Lab Haematol. 2004;26(3): 225-228.
16. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004;2(1):26-33.
17. El Beltagya KE, Al Balawib IA, Almuneefa M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.IJID. 2008;12(5): 495-499.
18. Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A,Skakni L.Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J. 2003;24(2):81-86.
19. Ayoola AE, Tobaigy MS, Gadour MO, Ahmed BS, Hamza MK. The decline of HBV viral infection in South-Western Saudi Arabia. Saudi Med J. 2003;24(9):991-995.
20. Al-Faleh FZ, Ayoola A, Al-Jeffry M, Arif M, Al-Rahsed R, Ramia S. Integration of hepatitis B vaccine into the expanded program on immunization: the Saudi Arabian experience. Ann Saudi Med. 1993;13(3):231-236.
21. Yong-lin Yang, Qiang Fu, Ming-shun Zhang, Jie Cai, Gui-ming Ma, Zu-hu Huang, et al. Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virol J. 2012;9(82):1-6.
22. Singh, B, Verma, M., Verma, K. Markers for transfusion-associated hepatitis in North India blood donors: prevalence and trends. Jpn J Infect Dis. 2004;57(2):49-51.
23. Van der Poel CL, Janssen MP, Borkent-Raven B. The collection, testing and use of blood and blood products in Europe in 2005. Final Report for the Council of Europe; 2009.
24. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 2009;49(8):1609-1620.
25. Panhotra BR, Al-Bahrani A, Ul-Hassan Z. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing. Saudi Med J.2005;26(2):270-273.
26. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implication for transfusion practice. Transfusion. 2007;4(1):74-79
27. Kleinman SH, Busch MP. HBV. amplified and back in the blood safety spotlight. Transfusion. 2001;41(9):1081-1085.
28. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang. 2006;91(1):1-12.
29. Mehdi SR, Pophali A, Al-Abdulrahim KA. Prevalence of hepatitis B and C among blood donors. Saudi Med J. 2000;21(10):942-944.
30. Nazar H, Nadia N, Shazia N, Zulfiqar A and Farhat A. Prevalence of hepatitis B and hepatitis C in blood donors of Karachi. Biomedica. 2008;24(9):116-117.
31. Fiekumo IB, Musa AM, and Zaccheaus AJ. Seroepidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfusion. 2009;7(4):293-299.
32. Mustafa AA and Yassir ME. Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital. Virol J. 2009;6(1):227.
33. World Health Organization (WHO). Report of the Regional Director. Blood Safety: A Strategy for the African Region Brazzaville. WHO: AFR/RC51/9 Rev.1:1-8; 2002.